The global Glucocorticoids market was valued at US$ 4850 million in 2023 and is anticipated to reach US$ 6690.5 million by 2030, witnessing a CAGR of 4.8% during the forecast period 2024-2030.

Glucocorticoids Market

Glucocorticoids are given in relatively large doses for the treatment and prevention of cerebral edema in patients with brain tumors and in some patients with bacterial meningitis.

Topical corticosteroids are steroid medications that are applied directly to the skin to reduce inflammation and irritation. Topical corticosteroids come in many different forms, including creams, lotions, and gels. Topical steroids are used to treat skin conditions such as rashes, dermatitis, itching, eczema, and psoriasis, and this segment is expected to dominate the market owing to growing geriatric population across the world, increase in skin conditions, and prolonging duration. Increasing prevalence of skin-related disorders and rising incidence of rashes, dermatitis, itching, eczema, and psoriasis are boosting the growth of the corticosteroid market.

This report aims to provide a comprehensive presentation of the global market for Glucocorticoids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucocorticoids.

Report Scope

The Glucocorticoids market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Glucocorticoids market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Glucocorticoids manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Glucocorticoids Market Report

Report Metric	Details
Report Name	Glucocorticoids Market
Accounted market size in 2023	US$ 4850 million
Forecasted market size in 2030	US$ 6690.5 million
CAGR	4.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Cortisone Prednisone Prednisolone Methylprednisolone Dexamethasone Betamethasone Hydrocortisone Others
Segment by Application	Anti-inflammatory Immunosuppressive Vasoconstrictive
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla, Abbott Laboratories, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd, Shandong Xinhua Pharmaceutical Company Limited, Yangzi River Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Glucocorticoids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Glucocorticoids in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Glucocorticoids Market growing?

Ans: The Glucocorticoids Market witnessing a CAGR of 4.8% during the forecast period 2024-2030.

What is the Glucocorticoids Market size in 2030?

Ans: The Glucocorticoids Market size in 2030 will be US$ 6690.5 million.

Who are the main players in the Glucocorticoids Market report?

Ans: The main players in the Glucocorticoids Market are Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla, Abbott Laboratories, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd, Shandong Xinhua Pharmaceutical Company Limited, Yangzi River Pharmaceutical Group

What are the Application segmentation covered in the Glucocorticoids Market report?

Ans: The Applications covered in the Glucocorticoids Market report are Anti-inflammatory, Immunosuppressive, Vasoconstrictive

What are the Type segmentation covered in the Glucocorticoids Market report?

Ans: The Types covered in the Glucocorticoids Market report are Cortisone, Prednisone, Prednisolone, Methylprednisolone, Dexamethasone, Betamethasone, Hydrocortisone, Others

1 Glucocorticoids Market Overview

1.1 Product Overview and Scope of Glucocorticoids

1.2 Glucocorticoids Segment by Type

1.2.1 Global Glucocorticoids Market Value Comparison by Type (2024-2030)

1.2.2 Cortisone

1.2.3 Prednisone

1.2.4 Prednisolone

1.2.5 Methylprednisolone

1.2.6 Dexamethasone

1.2.7 Betamethasone

1.2.8 Hydrocortisone

1.2.9 Others

1.3 Glucocorticoids Segment by Application

1.3.1 Global Glucocorticoids Market Value by Application: (2024-2030)

1.3.2 Anti-inflammatory

1.3.3 Immunosuppressive

1.3.4 Vasoconstrictive

1.4 Global Glucocorticoids Market Size Estimates and Forecasts

1.4.1 Global Glucocorticoids Revenue 2019-2030

1.4.2 Global Glucocorticoids Sales 2019-2030

1.4.3 Global Glucocorticoids Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Glucocorticoids Market Competition by Manufacturers

2.1 Global Glucocorticoids Sales Market Share by Manufacturers (2019-2024)

2.2 Global Glucocorticoids Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Glucocorticoids Average Price by Manufacturers (2019-2024)

2.4 Global Glucocorticoids Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Glucocorticoids, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Glucocorticoids, Product Type & Application

2.7 Glucocorticoids Market Competitive Situation and Trends

2.7.1 Glucocorticoids Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Glucocorticoids Players Market Share by Revenue

2.7.3 Global Glucocorticoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Glucocorticoids Retrospective Market Scenario by Region

3.1 Global Glucocorticoids Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Glucocorticoids Global Glucocorticoids Sales by Region: 2019-2030

3.2.1 Global Glucocorticoids Sales by Region: 2019-2024

3.2.2 Global Glucocorticoids Sales by Region: 2025-2030

3.3 Global Glucocorticoids Global Glucocorticoids Revenue by Region: 2019-2030

3.3.1 Global Glucocorticoids Revenue by Region: 2019-2024

3.3.2 Global Glucocorticoids Revenue by Region: 2025-2030

3.4 North America Glucocorticoids Market Facts & Figures by Country

3.4.1 North America Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Glucocorticoids Sales by Country (2019-2030)

3.4.3 North America Glucocorticoids Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Glucocorticoids Market Facts & Figures by Country

3.5.1 Europe Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Glucocorticoids Sales by Country (2019-2030)

3.5.3 Europe Glucocorticoids Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Glucocorticoids Market Facts & Figures by Country

3.6.1 Asia Pacific Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Glucocorticoids Sales by Country (2019-2030)

3.6.3 Asia Pacific Glucocorticoids Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Glucocorticoids Market Facts & Figures by Country

3.7.1 Latin America Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Glucocorticoids Sales by Country (2019-2030)

3.7.3 Latin America Glucocorticoids Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Glucocorticoids Market Facts & Figures by Country

3.8.1 Middle East and Africa Glucocorticoids Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Glucocorticoids Sales by Country (2019-2030)

3.8.3 Middle East and Africa Glucocorticoids Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Glucocorticoids Sales by Type (2019-2030)

4.1.1 Global Glucocorticoids Sales by Type (2019-2024)

4.1.2 Global Glucocorticoids Sales by Type (2025-2030)

4.1.3 Global Glucocorticoids Sales Market Share by Type (2019-2030)

4.2 Global Glucocorticoids Revenue by Type (2019-2030)

4.2.1 Global Glucocorticoids Revenue by Type (2019-2024)

4.2.2 Global Glucocorticoids Revenue by Type (2025-2030)

4.2.3 Global Glucocorticoids Revenue Market Share by Type (2019-2030)

4.3 Global Glucocorticoids Price by Type (2019-2030)

5 Segment by Application

5.1 Global Glucocorticoids Sales by Application (2019-2030)

5.1.1 Global Glucocorticoids Sales by Application (2019-2024)

5.1.2 Global Glucocorticoids Sales by Application (2025-2030)

5.1.3 Global Glucocorticoids Sales Market Share by Application (2019-2030)

5.2 Global Glucocorticoids Revenue by Application (2019-2030)

5.2.1 Global Glucocorticoids Revenue by Application (2019-2024)

5.2.2 Global Glucocorticoids Revenue by Application (2025-2030)

5.2.3 Global Glucocorticoids Revenue Market Share by Application (2019-2030)

5.3 Global Glucocorticoids Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Corporation Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Pfizer Glucocorticoids Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Description and Business Overview

6.2.3 Novartis Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Novartis Glucocorticoids Product Portfolio

6.2.5 Novartis Recent Developments/Updates

6.3 Aspen

6.3.1 Aspen Corporation Information

6.3.2 Aspen Description and Business Overview

6.3.3 Aspen Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Aspen Glucocorticoids Product Portfolio

6.3.5 Aspen Recent Developments/Updates

6.4 Euroapi

6.4.1 Euroapi Corporation Information

6.4.2 Euroapi Description and Business Overview

6.4.3 Euroapi Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Euroapi Glucocorticoids Product Portfolio

6.4.5 Euroapi Recent Developments/Updates

6.5 Sanofi

6.5.1 Sanofi Corporation Information

6.5.2 Sanofi Description and Business Overview

6.5.3 Sanofi Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Sanofi Glucocorticoids Product Portfolio

6.5.5 Sanofi Recent Developments/Updates

6.6 Avik Pharmaceutical Limited

6.6.1 Avik Pharmaceutical Limited Corporation Information

6.6.2 Avik Pharmaceutical Limited Description and Business Overview

6.6.3 Avik Pharmaceutical Limited Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Avik Pharmaceutical Limited Glucocorticoids Product Portfolio

6.6.5 Avik Pharmaceutical Limited Recent Developments/Updates

6.7 Symbiotec

6.6.1 Symbiotec Corporation Information

6.6.2 Symbiotec Description and Business Overview

6.6.3 Symbiotec Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Symbiotec Glucocorticoids Product Portfolio

6.7.5 Symbiotec Recent Developments/Updates

6.8 Cipla

6.8.1 Cipla Corporation Information

6.8.2 Cipla Description and Business Overview

6.8.3 Cipla Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Cipla Glucocorticoids Product Portfolio

6.8.5 Cipla Recent Developments/Updates

6.9 Abbott Laboratories

6.9.1 Abbott Laboratories Corporation Information

6.9.2 Abbott Laboratories Description and Business Overview

6.9.3 Abbott Laboratories Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Abbott Laboratories Glucocorticoids Product Portfolio

6.9.5 Abbott Laboratories Recent Developments/Updates

6.10 Tianjin Tianyao Pharmaceuticals Co., Ltd.

6.10.1 Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information

6.10.2 Tianjin Tianyao Pharmaceuticals Co., Ltd. Description and Business Overview

6.10.3 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product Portfolio

6.10.5 Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates

6.11 Zhejiang Xianju Pharmaceutical Co.,Ltd

6.11.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information

6.11.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Description and Business Overview

6.11.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product Portfolio

6.11.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates

6.12 Shandong Xinhua Pharmaceutical Company Limited

6.12.1 Shandong Xinhua Pharmaceutical Company Limited Corporation Information

6.12.2 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Description and Business Overview

6.12.3 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product Portfolio

6.12.5 Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates

6.13 Yangzi River Pharmaceutical Group

6.13.1 Yangzi River Pharmaceutical Group Corporation Information

6.13.2 Yangzi River Pharmaceutical Group Glucocorticoids Description and Business Overview

6.13.3 Yangzi River Pharmaceutical Group Glucocorticoids Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Yangzi River Pharmaceutical Group Glucocorticoids Product Portfolio

6.13.5 Yangzi River Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Glucocorticoids Industry Chain Analysis

7.2 Glucocorticoids Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Glucocorticoids Production Mode & Process

7.4 Glucocorticoids Sales and Marketing

7.4.1 Glucocorticoids Sales Channels

7.4.2 Glucocorticoids Distributors

7.5 Glucocorticoids Customers

8 Glucocorticoids Market Dynamics

8.1 Glucocorticoids Industry Trends

8.2 Glucocorticoids Market Drivers

8.3 Glucocorticoids Market Challenges

8.4 Glucocorticoids Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

TIANJIN TIANYAO PHARMACEUTICALS CO LTD

Zhejiang Xianju Pharmaceutical Co., Ltd.

Shandong Xinhua Pharmaceutical Company Limited

Yangzi River Pharmaceutical Group

Avik Pharmaceutical Limited

Abbott Laboratories

Pfizer Inc

List of Tables

Table 1. Global Glucocorticoids Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Glucocorticoids Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Glucocorticoids Market Competitive Situation by Manufacturers in 2023

Table 4. Global Glucocorticoids Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Glucocorticoids Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Glucocorticoids Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Glucocorticoids Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Glucocorticoids Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Glucocorticoids, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Glucocorticoids, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Glucocorticoids, Product Type & Application

Table 12. Global Key Manufacturers of Glucocorticoids, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Glucocorticoids by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucocorticoids as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Glucocorticoids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Glucocorticoids Sales by Region (2019-2024) & (K Units)

Table 18. Global Glucocorticoids Sales Market Share by Region (2019-2024)

Table 19. Global Glucocorticoids Sales by Region (2025-2030) & (K Units)

Table 20. Global Glucocorticoids Sales Market Share by Region (2025-2030)

Table 21. Global Glucocorticoids Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Glucocorticoids Revenue Market Share by Region (2019-2024)

Table 23. Global Glucocorticoids Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Glucocorticoids Revenue Market Share by Region (2025-2030)

Table 25. North America Glucocorticoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Glucocorticoids Sales by Country (2019-2024) & (K Units)

Table 27. North America Glucocorticoids Sales by Country (2025-2030) & (K Units)

Table 28. North America Glucocorticoids Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Glucocorticoids Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Glucocorticoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Glucocorticoids Sales by Country (2019-2024) & (K Units)

Table 32. Europe Glucocorticoids Sales by Country (2025-2030) & (K Units)

Table 33. Europe Glucocorticoids Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Glucocorticoids Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Glucocorticoids Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Glucocorticoids Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Glucocorticoids Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Glucocorticoids Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Glucocorticoids Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Glucocorticoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Glucocorticoids Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Glucocorticoids Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Glucocorticoids Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Glucocorticoids Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Glucocorticoids Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Glucocorticoids Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Glucocorticoids Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Glucocorticoids Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Glucocorticoids Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Glucocorticoids Sales (K Units) by Type (2019-2024)

Table 51. Global Glucocorticoids Sales (K Units) by Type (2025-2030)

Table 52. Global Glucocorticoids Sales Market Share by Type (2019-2024)

Table 53. Global Glucocorticoids Sales Market Share by Type (2025-2030)

Table 54. Global Glucocorticoids Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Glucocorticoids Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Glucocorticoids Revenue Market Share by Type (2019-2024)

Table 57. Global Glucocorticoids Revenue Market Share by Type (2025-2030)

Table 58. Global Glucocorticoids Price (US$/Unit) by Type (2019-2024)

Table 59. Global Glucocorticoids Price (US$/Unit) by Type (2025-2030)

Table 60. Global Glucocorticoids Sales (K Units) by Application (2019-2024)

Table 61. Global Glucocorticoids Sales (K Units) by Application (2025-2030)

Table 62. Global Glucocorticoids Sales Market Share by Application (2019-2024)

Table 63. Global Glucocorticoids Sales Market Share by Application (2025-2030)

Table 64. Global Glucocorticoids Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Glucocorticoids Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Glucocorticoids Revenue Market Share by Application (2019-2024)

Table 67. Global Glucocorticoids Revenue Market Share by Application (2025-2030)

Table 68. Global Glucocorticoids Price (US$/Unit) by Application (2019-2024)

Table 69. Global Glucocorticoids Price (US$/Unit) by Application (2025-2030)

Table 70. Pfizer Corporation Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Pfizer Glucocorticoids Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Novartis Corporation Information

Table 76. Novartis Description and Business Overview

Table 77. Novartis Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Novartis Glucocorticoids Product

Table 79. Novartis Recent Developments/Updates

Table 80. Aspen Corporation Information

Table 81. Aspen Description and Business Overview

Table 82. Aspen Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Aspen Glucocorticoids Product

Table 84. Aspen Recent Developments/Updates

Table 85. Euroapi Corporation Information

Table 86. Euroapi Description and Business Overview

Table 87. Euroapi Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Euroapi Glucocorticoids Product

Table 89. Euroapi Recent Developments/Updates

Table 90. Sanofi Corporation Information

Table 91. Sanofi Description and Business Overview

Table 92. Sanofi Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Sanofi Glucocorticoids Product

Table 94. Sanofi Recent Developments/Updates

Table 95. Avik Pharmaceutical Limited Corporation Information

Table 96. Avik Pharmaceutical Limited Description and Business Overview

Table 97. Avik Pharmaceutical Limited Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Avik Pharmaceutical Limited Glucocorticoids Product

Table 99. Avik Pharmaceutical Limited Recent Developments/Updates

Table 100. Symbiotec Corporation Information

Table 101. Symbiotec Description and Business Overview

Table 102. Symbiotec Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Symbiotec Glucocorticoids Product

Table 104. Symbiotec Recent Developments/Updates

Table 105. Cipla Corporation Information

Table 106. Cipla Description and Business Overview

Table 107. Cipla Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Cipla Glucocorticoids Product

Table 109. Cipla Recent Developments/Updates

Table 110. Abbott Laboratories Corporation Information

Table 111. Abbott Laboratories Description and Business Overview

Table 112. Abbott Laboratories Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Abbott Laboratories Glucocorticoids Product

Table 114. Abbott Laboratories Recent Developments/Updates

Table 115. Tianjin Tianyao Pharmaceuticals Co., Ltd. Corporation Information

Table 116. Tianjin Tianyao Pharmaceuticals Co., Ltd. Description and Business Overview

Table 117. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Tianjin Tianyao Pharmaceuticals Co., Ltd. Glucocorticoids Product

Table 119. Tianjin Tianyao Pharmaceuticals Co., Ltd. Recent Developments/Updates

Table 120. Zhejiang Xianju Pharmaceutical Co.,Ltd Corporation Information

Table 121. Zhejiang Xianju Pharmaceutical Co.,Ltd Description and Business Overview

Table 122. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Zhejiang Xianju Pharmaceutical Co.,Ltd Glucocorticoids Product

Table 124. Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates

Table 125. Shandong Xinhua Pharmaceutical Company Limited Corporation Information

Table 126. Shandong Xinhua Pharmaceutical Company Limited Description and Business Overview

Table 127. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Shandong Xinhua Pharmaceutical Company Limited Glucocorticoids Product

Table 129. Shandong Xinhua Pharmaceutical Company Limited Recent Developments/Updates

Table 130. Yangzi River Pharmaceutical Group Corporation Information

Table 131. Yangzi River Pharmaceutical Group Description and Business Overview

Table 132. Yangzi River Pharmaceutical Group Glucocorticoids Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Yangzi River Pharmaceutical Group Glucocorticoids Product

Table 134. Yangzi River Pharmaceutical Group Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Glucocorticoids Distributors List

Table 138. Glucocorticoids Customers List

Table 139. Glucocorticoids Market Trends

Table 140. Glucocorticoids Market Drivers

Table 141. Glucocorticoids Market Challenges

Table 142. Glucocorticoids Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Glucocorticoids

Figure 2. Global Glucocorticoids Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Glucocorticoids Market Share by Type in 2023 & 2030

Figure 4. Cortisone Product Picture

Figure 5. Prednisone Product Picture

Figure 6. Prednisolone Product Picture

Figure 7. Methylprednisolone Product Picture

Figure 8. Dexamethasone Product Picture

Figure 9. Betamethasone Product Picture

Figure 10. Hydrocortisone Product Picture

Figure 11. Others Product Picture

Figure 12. Global Glucocorticoids Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Glucocorticoids Market Share by Application in 2023 & 2030

Figure 14. Anti-inflammatory

Figure 15. Immunosuppressive

Figure 16. Vasoconstrictive

Figure 17. Global Glucocorticoids Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Glucocorticoids Market Size (2019-2030) & (US$ Million)

Figure 19. Global Glucocorticoids Sales (2019-2030) & (K Units)

Figure 20. Global Glucocorticoids Average Price (US$/Unit) & (2019-2030)

Figure 21. Glucocorticoids Report Years Considered

Figure 22. Glucocorticoids Sales Share by Manufacturers in 2023

Figure 23. Global Glucocorticoids Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Glucocorticoids Players: Market Share by Revenue in 2023

Figure 25. Glucocorticoids Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Glucocorticoids Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Glucocorticoids Sales Market Share by Country (2019-2030)

Figure 28. North America Glucocorticoids Revenue Market Share by Country (2019-2030)

Figure 29. United States Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Glucocorticoids Sales Market Share by Country (2019-2030)

Figure 32. Europe Glucocorticoids Revenue Market Share by Country (2019-2030)

Figure 33. Germany Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Glucocorticoids Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Glucocorticoids Revenue Market Share by Region (2019-2030)

Figure 40. China Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. China Taiwan Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Latin America Glucocorticoids Sales Market Share by Country (2019-2030)

Figure 48. Latin America Glucocorticoids Revenue Market Share by Country (2019-2030)

Figure 49. Mexico Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Brazil Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Argentina Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Middle East & Africa Glucocorticoids Sales Market Share by Country (2019-2030)

Figure 53. Middle East & Africa Glucocorticoids Revenue Market Share by Country (2019-2030)

Figure 54. Turkey Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. UAE Glucocorticoids Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Global Sales Market Share of Glucocorticoids by Type (2019-2030)

Figure 58. Global Revenue Market Share of Glucocorticoids by Type (2019-2030)

Figure 59. Global Glucocorticoids Price (US$/Unit) by Type (2019-2030)

Figure 60. Global Sales Market Share of Glucocorticoids by Application (2019-2030)

Figure 61. Global Revenue Market Share of Glucocorticoids by Application (2019-2030)

Figure 62. Global Glucocorticoids Price (US$/Unit) by Application (2019-2030)

Figure 63. Glucocorticoids Value Chain

Figure 64. Glucocorticoids Production Process

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Distributors Profiles

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions